http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107664696-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2017-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107664696-B |
| titleOfInvention | A double-antibody sandwich ELISA kit for the diagnosis of adult glioma |
| abstract | The invention discloses the application of serum CCKBR as a diagnostic marker for glioma, and a double-antibody sandwich ELISA diagnostic kit for glioma. The invention discloses a new biological marker for diagnosing glioma, especially for early warning and early diagnosis of glioma, which has a particularly important role and clinical application value. At the same time, an enzyme-linked immunoassay diagnostic system based on the double-antibody sandwich principle has also been established, and a glioma diagnostic kit has been developed, which can quickly and accurately detect CCKBR, and can detect various stages (especially early) primary It has important clinical application value for rapid auxiliary diagnosis of glioma. Moreover, the kit has the advantages of simple operation, stable reagents, good repeatability, strong specificity, and high sensitivity, and has broad market prospects for easy popularization and application in a wide range. |
| priorityDate | 2017-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.